From: Characterization of the human myelin oligodendrocyte glycoprotein antibody response in demyelination
 | Total cohort | Limited cohort | ||
---|---|---|---|---|
Sensitivity % (CI) | Specificity % (CI) | Sensitivity % (CI) | Specificity % (CI) | |
Children | N = 171 |  | N = 80 |  |
 Live flow assay IgG (H + L)a | 89.7 (83–94) | 97.1 (83.4–99.9) | 87.9 (77–94.3) | 100 (73.2–100) |
 Live flow assay (IgG1)b | 89.8 (82.8–94.2) | 94.3 (79.5–99) | 88.3 (76.8–94.8) | 100 (73.2–100) |
 Fixed flow assaya | 50.7 (42.1–59.4) | 100 (87.7–100) | 43.9 (31.9–56.7) | 100 (73.2–100) |
 Fixed biochip assaya | – | – | 60.6 (47.8–72.2) | 100 (73.2–100) |
Adults | N = 172 |  | N = 70 |  |
 Live flow assay IgG (H + L)a | 93.9 (88–97.2) | 97.5 (85.3–99.9) | 92.3 (80.6–97.5) | 100 (78.1–100) |
 Live flow assay (IgG1)b | 87.7 (80.5–92.6) | 97.5 (85.3–99.9) | 81.5 (68.1–90.3) | 95.5 (75.1–99.8) |
 Fixed flow assaya | 52.3 (43.4–61) | 100 (89.1–100) | 50 (36–64) | 100 (78.1–100) |
 Fixed biochip assaya | – | – | 55.8 (41.4–69.3) | 100 (56.1–100) |